These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21822161)

  • 1. Secondary pseudomyopia induced by amisulpride.
    Stratos AA; Peponis VG; Portaliou DM; Stroubini TE; Skouriotis S; Kymionis GD
    Optom Vis Sci; 2011 Nov; 88(11):1380-2. PubMed ID: 21822161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole-induced transient myopia: A rare entity.
    Praveen Kumar KV; Chiranjeevi P; Alam MS
    Indian J Ophthalmol; 2018 Jan; 66(1):130-131. PubMed ID: 29283140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
    Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C
    Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
    Delcker A; Schoon ML; Oczkowski B; Gaertner HJ
    Pharmacopsychiatry; 1990 May; 23(3):125-30. PubMed ID: 1973843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
    Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?
    Blin O
    Encephale; 2000 Oct; 26 Spec No 1():7-11. PubMed ID: 11294060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.
    Papadimitriou GN; Theleritis CG; Dikeos DG; Psarros CJ; Soldatos CR
    Int Clin Psychopharmacol; 2006 May; 21(3):181-4. PubMed ID: 16528141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amisulpride for clozapine induced sialorrhea.
    Aggarwal A; Sharma DD
    Psychopharmacol Bull; 2009; 42(4):69-71. PubMed ID: 20581795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride--an open clinical study of a new benzamide in schizophrenic patients.
    Mann K; Bartels M; Bauer H; Gaertner HJ
    Pharmacopsychiatry; 1984 Jul; 17(4):111-5. PubMed ID: 6147865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amisulpride related tic-like symptoms in an adolescent schizophrenic.
    Lin CL; Shiah IS; Yeh CB; Wan FJ; Wang TS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):144-6. PubMed ID: 16225977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ
    Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.
    Surguladze S; Patel A; Kerwin RW; Knapp M; Travis MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):517-22. PubMed ID: 15866352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole induced transient myopia: a case report and review of literature.
    Nair AG; Nair AG; George RJ; Biswas J; Gandhi RA
    Cutan Ocul Toxicol; 2012 Mar; 31(1):74-6. PubMed ID: 21830909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride-induced tardive dystonia: a case report.
    Guriz O; Ekinci AE; Orsel S; Ekinci O
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):412-3. PubMed ID: 19944732
    [No Abstract]   [Full Text] [Related]  

  • 19. Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
    Psarros C; Theleritis CG; Paparrigopoulos TJ; Politis AM; Papadimitriou GN
    Int J Geriatr Psychiatry; 2009 May; 24(5):518-22. PubMed ID: 19072747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dystonia associated with low-dose of amisulpride: a case report.
    Sevincok L; Balci V; Akyildiz U
    J Clin Psychopharmacol; 2008 Oct; 28(5):573-4. PubMed ID: 18794659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.